Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc." Results 181 - 200 of 289
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Feb 2013, 7:23 am by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509, U.S. 579 (1993). [read post]
11 Feb 2013, 4:37 am by Susan Brenner
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
24 Jan 2013, 8:09 am by Alex Craigie
Merrell Dow Pharmaceuticals, Inc. (509 U.S. 579), federal courts have applied a different standard. [read post]
27 Dec 2012, 5:07 am by Erin Kristofco
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 593-94 (1993) are relevant to the Court’s reliability determination under CRE 702, which is identical to FRE 702. [read post]
24 Dec 2012, 9:58 am by Schachtman
Merrell Dow Pharmaceuticals Inc., 509 U.S. 579 (1993), a case that has been superseded by subsequent cases and a revision to the operative statute, Rule 702. [read post]
28 Jun 2012, 5:52 am
Merrell Dow Pharmaceuticals apply to expert evidence offered at class certification? [read post]
28 Jun 2012, 5:52 am
Merrell Dow Pharmaceuticals apply to expert evidence offered at class certification? [read post]
10 Jun 2012, 1:09 pm by Schachtman
Merrell Dow Pharms., Inc., 874 F.2d 307, 311 (5th Cir. 1989) (noting that “[o]ne difficulty with epidemiologic studies is that often several factors can cause the same disease. [read post]